Sarcomas comprise a heterogeneous group of malignant neoplasms that include genomically simple and genomically complex subtypes. This consensus provides guidelines for efficient, rational use of next-generation sequencing in their clinical management.

This consensus review establishes guidelines for the rational and efficient use of next-generation sequencing−based technology in the clinical management of sarcoma.